Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Annette Vogl, PhD
VP, Biology and Translational Research at Tubulis
Speaker

Profile

With Tubulis since 2020; heading the Biology department; current position at Tubulis VP Biology and Translational Research. Tubulis is a Munich based biotech company developing next-generation ADCs with novel linker chemistry. Before joining Tubulis I worked at Genentech from 2015-2020, focusing on protein degradation and neurodegenerative diseases. Holding a PhD in Neurobiology and Neurosciences from the Max Planck Institute of Psychiatry and the Technical University of Munich.

Agenda Sessions

  • The Tubutecan ADC Platform – Highlighting the Development of TUB-040, A Next-generation NaPi2b-targeting ADC with Stably Linked Exatecan

    , 14:15
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Annette at Antibody Engineering & Therapeutics Europe